Effects of Sedation on Spinal Anesthesia-induced Maternal Hypotension

April 8, 2016 updated by: Dr.Cenk Sahan, Van Training and Research Hospital

Effects of Sedation on Spinal Anesthesia-induced Maternal Hypotension in Preoperatively Anxious Parturients Undergoing Urgent Category-1 Cesarean Section: A Historical Cohort Study

Background: This study was designed to investigate the effect of sedation on the occurrence of maternal hypotension in preoperatively anxious parturients undergoing urgent category-1 Cesarean section (C/S) under spinal anesthesia.

Methods: After institutional ethics committee approval, prospectively collected data of 1824 parturients undergoing C/S were reviewed. Parturients with high preoperative anxiety scores (visual analogue scale for anxiety (VAS-A)≥70) undergoing C/S under spinal anesthesia with thiopental (Group S=49) and without any other type of sedation (Group NS=53) were included in the analysis. Hemodynamic parameters were documented and maximum systolic arterial pressure (SAP) reductions from the baseline after spinal anesthesia were calculated. Incidences of hypotension (SAP≥30% decrease from baseline or <100 mmHg) and bradycardia (HR<55 beats/min), and related-ephedrine and -atropine requirements were noted. Our primary endpoint was to compare the maximum SAP reductions from the baseline values in Groups S and NS. Secondary endpoints were incidences of hypotension and bradycardia, required ephedrine and atropine doses, newborn Apgar scores at 1st and 5th min.

Study Overview

Detailed Description

Background: This study was designed to investigate the effect of thiopental sodium sedation on the occurrence of maternal hypotension in preoperatively anxious parturients undergoing urgent category-1 Cesarean section (C/S) under spinal anesthesia.

Methods: After institutional ethics committee approval, prospectively collected data of 1824 parturients undergoing C/S at Van Training and Research Hospital between August 2014 and February 2015 were reviewed. Parturients with high preoperative anxiety scores (visual analogue scale for anxiety (VAS-A)≥70) undergoing C/S under spinal anesthesia with thiopental (Group S=49) and without any other type of sedation (Group NS=53) were included in the analysis. All parturients received SA with hyperbaric bupivacaine 0.5% 2.5 mL. Hemodynamic parameters were documented and maximum systolic arterial pressure (SAP) reductions from the baseline after spinal anesthesia were calculated. Incidences of hypotension (SAP≥30% decrease from baseline or <100 mmHg) and bradycardia (HR<55 beats/min), and related-ephedrine and -atropine requirements were noted. All data were obtained from the surgical database and patient charts. Primary endpoint of our study was to compare the maximum SAP reductions from the baseline values in Groups S and NS. Secondary endpoints were incidences of hypotension and bradycardia, required ephedrine and atropine doses, newborn Apgar scores at 1st and 5th min.

Study Type

Observational

Enrollment (Actual)

102

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Van, Turkey
        • Van Training and Research Hospital, Department of Anesthesiology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Parturients undergoing urgent category-1 Cesarean section (C/S) under spinal anesthesia

Description

Inclusion Criteria:

  • Urgent category-1 C/S
  • ASA physical status I-II
  • Aged between 18 and 35 years
  • Term (≥37 weeks) singleton pregnancy
  • BMI <40 kg/m2
  • Height >150 cm or <180 cm
  • High preoperative anxiety scores (visual analogue scale for anxiety (VAS-A) ≥70)
  • Spinal anesthesia with thiopental sodium sedation
  • Spinal anesthesia without any sedation

Exclusion Criteria:

  • Preoperative prehydration
  • Placenta previa
  • Placenta accreta
  • Hypertension
  • Pregnancy-induced hypertension
  • Urgent category ≥2
  • General anesthesia
  • Spinal anesthesia with sedation other than thiopental sodium

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Sedation (S)
Parturients who received IV thiopental 2 mg kg-1 and if necessary additional 50 mg immediately after spinal anesthesia until reaching at least Ramsay sedation score of 3 (1: patient anxious, agitated or restless, 6: patient with no response to light glabella tap or loud auditory stimulus.).
Parturients who received IV thiopental 2 mg kg-1 and if necessary additional 50 mg immediately after spinal anesthesia until reaching at least Ramsay sedation score of 3 (1: patient anxious, agitated or restless, 6: patient with no response to light glabella tap or loud auditory stimulus.).
Other Names:
  • Thiopental
No sedation (NS)
Parturients who did not receive any sedative agent after the spinal anesthesia performance.
Parturients did not receive any type of sedation after spinal anesthesia.
Other Names:
  • No drug

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximum systolic arterial pressure (SAP) reductions from the baseline values
Time Frame: 0-10 minutes
% SAP reduction after spinal anesthesia
0-10 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of maternal hypotension
Time Frame: 0-30 minutes
Incidence of hypotension during the surgery (decrease in SAP >30% from baseline or an absolute value <100 mmHg)
0-30 minutes
Incidence of maternal bradycardia
Time Frame: 0-30 minutes
Incidence of bradycardia during the surgery (heart rate (HR) <55 beats min-1)
0-30 minutes
Ephedrine requirement
Time Frame: 0-30 minutes
Ephedrine 5 mg IV boluses were administered with 2 min intervals until SAP returned to a value of >100 mmHg
0-30 minutes
Atropine requirement
Time Frame: 0-30 minutes
Bolus of IV 0.5 mg atropine was given if bradycardia (HR <55 beats min-1) occurred
0-30 minutes
Incidence of maternal nausea
Time Frame: 0-30 minutes
If any during the Cesarean section, recorded
0-30 minutes
Incidence of maternal vomiting
Time Frame: 0-30 minutes
If any during the Cesarean section, recorded
0-30 minutes
Newborn Apgar score 1st min
Time Frame: 1st min
Apgar score at 1st min (0-3: severely depressed, 4-6: moderately depressed, 7-10: excellent condition)
1st min
Newborn Apgar score 5th min
Time Frame: 5th min
Apgar score at 5th min (0-3: severely depressed, 4-6: moderately depressed, 7-10: excellent condition)
5th min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cenk Sahan, MD, Design and conduct the study, review and analyze the data, and write the manuscript

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Actual)

February 1, 2015

Study Completion (Actual)

February 1, 2015

Study Registration Dates

First Submitted

April 4, 2016

First Submitted That Met QC Criteria

April 4, 2016

First Posted (Estimate)

April 8, 2016

Study Record Updates

Last Update Posted (Estimate)

April 11, 2016

Last Update Submitted That Met QC Criteria

April 8, 2016

Last Verified

April 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Section

Clinical Trials on Sedation

3
Subscribe